Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AstraZeneca confirms safety of Crestor

May 26, 2004

Novel dual lipid synthesis inhibitor effective for metabolic syndrome and dyslipidemia

May 26, 2004

Yamanouchi presents activators of PGC-1 and mtTFA genes and their therapeutic use

May 25, 2004

Glufast launched in Japan

May 25, 2004

Banyu researchers design novel NPY antagonists

May 24, 2004

CyrRx in-licenses intellectual property covering drug screening method using Rip140

May 24, 2004

DeveloGen and Peptor finalize merger

May 24, 2004

Amino acid conjugated small molecule lowers blood glucose in insulin-resistant mice

May 24, 2004

Progesterone cream ineffective as postmenopausal bone loss prophylaxis

May 21, 2004

Ospemifene reduces markers of bone turnover in postmenopausal women

May 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...